Join us on April 22nd for an exclusive webinar on #CGT development! Gain expert knowledge on optimizing #plasmid and #LVV production timelines, ensuring regulatory compliance, and navigating IND and BLA applications across global agencies. Don't miss this opportunity to stay ahead in the evolving CGT landscape!
Topic 1
Plasmid Applications and Production Challenges in Cell and Gene Therapy
Luffy Chen, Head of Plasmid PD and Production Dept., ProBio
Topic 2
Lessons from IND Clearances in CAR-T Development: From LVV Process Development to IND
Yucheng Lu, Sr. Scientist, Virus Manufacturing Dept., ProBio
Topic 3
CMC Regulatory Considerations for CGT Products
Tina Yu, Sr. Director of Regulatory Affairs Dept., ProBio
Don't miss this opportunity!
Register now
info@wilam.comAn initiative ofBioMelbourne NetworkLevel 6, HWT Tower40 City RoadSouthbank, VIC 3006
Wilam means home in the Woi-wurrung language of the Wurundjeri People of the Kulin Nation, the Traditional Owners of the lands on which we are based.We respectfully acknowledge the Traditional Custodians of the unceded lands and waters of Victoria, the Bunurong, Eastern Maar, Gunaikurnai, Wadawurrung and Wurundjeri Woi-wurrung peoples, on which we live and work. We pay respect to their Elders past and present. We acknowledge the significant contribution that they and other Aboriginal and Torres Strait Islander people have made and continue to make to the research and knowledge systems that inform our community and our sector. We acknowledge that Aboriginal and Torres Strait Islander people continue to live in a spiritual and sacred relationship with this country and recognise our responsibility to continue to work towards reconciliation.